SoFi Technologies vs. Upstart: Which Fintech Stock Is the Better Long-Term Buy?

The article argues SoFi is the better long-term fintech play versus Upstart, despite a Muddy Waters short report alleging financial engineering and prompting legal action from SoFi. SoFi reported 38% adjusted revenue growth in 2025, expects 30% growth in 2026, and is trading about 50% below its record at a forward P/E of 27.8. Upstart’s business is described as highly cyclical, with strong performance in falling-rate environments but declining loan volumes and revenue when rates rose; management guides for 40% revenue growth in 2026.

Analysis

The market is treating both names like high-beta fintech proxies, but the second-order split is between balance-sheet credibility and business-model reflexivity. SOFI’s real edge is that it is quietly evolving from an originator into a relationship-led financial platform, which should compress funding volatility over time and make earnings less rate-sensitive than the market assumes. UPST, by contrast, remains a spread and volume engine whose economics can snap back sharply in easing cycles, but that same operating leverage cuts the other way when credit tightens or risk appetite fades.

The short-report overhang on SOFI is less about near-term earnings math than about multiple duration: even if the allegations prove noisy, they can keep institutional ownership capped and raise the equity-risk premium for months. That creates a tactical buying opportunity only if management can keep printing clean GAAP profitability and avoid any perception of aggressive loan accounting. For UPST, the bank-charter path is strategically important because cheap deposit funding could stabilize unit economics, but it also increases regulatory scrutiny and may reduce the pure optionality investors currently pay for.

The contrarian miss is that the better trade may not be outright long SOFI vs long UPST, but long SOFI quality compounder vs short UPST rate beta. If growth slows or the Fed stays higher for longer, UPST’s valuation is the one most likely to de-rate because the market is still pricing in a normalized macro backdrop that has not yet arrived. Conversely, SOFI can underperform on headlines while still compounding fundamental value; that gap is where patient capital can earn alpha.

Near term, the catalyst path is asymmetric: SOFI gets a months-long prove-it window around earnings, regulatory optics, and insider behavior; UPST’s stock will likely react fastest to any change in rate-cut expectations. In a stable or easing rate environment, UPST can outperform sharply, but the downside if rate cuts are delayed is more immediate because its model has less earnings cushion.

Key Decisions for Investors

• Long SOFI / short UPST as a 3-6 month relative-value pair; thesis is quality compounding versus rate-beta reflexivity, with upside if rates stay sticky and downside limited by SOFI’s profitability trajectory.
• If entering SOFI, use a staged buy over the next 2 earnings cycles rather than chasing headlines; the risk/reward improves if the stock remains discounted despite continued GAAP profitability and no accounting fallout.
• For UPST, prefer put spreads or a tactical short ahead of macro data and Fed meetings; the trade works best if rate-cut expectations are pushed out, with asymmetric downside from a compressed multiple.
• Avoid outright long UPST into a benign macro squeeze unless paired with a rates hedge; the stock’s beta to falling yields can create fast upside, but the reversal risk is equally violent if the market reprices the easing path.
• Monitor SOFI insider buys and any regulatory commentary as signal, not noise; if management confidence persists and the short thesis fails to gain traction, the stock can rerate quickly from a low-quality narrative discount.